Financhill
Back

ADMA Biologics 10K Form

Buy
93

ADMA
ADMA Biologics

Last Price:
6.59
Seasonality Move:
-0.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ADMA News And Ratings

See the #1 stock for the next 7 days that we like better than ADMA

ADMA Financial Statistics

Sales & Book Value

Annual Sales: $258.22M
Cash Flow: $16.19M
Price / Cash Flow: 387.06
Annual Sales: $0.60
Price / Book: 11.14

Profitability

EPS (TTM): -0.13000
Net Income (TTM): $-28.24M
Gross Margin: $88.94M
Return on Equity: -19.31%
Return on Assets: -8.26%

ADMA Biologics Earnings Forecast

Key ADMA Biologics Financial Ratios

  • The Gross Profit Margin over the past 14 years for ADMA is 34.44%.
  • The Selling, General & Administrative Expenses for ADMA have been equal to 22.86% of Gross Profit Margin.
  • The Research & Development expenses have been 1.28% of Revenue.
  • The Interest Expense is -88.63% of Operating Income.
  • The Net Earning history of ADMA is -10.94% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 9 years.

ADMA Biologics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: ADMA
CUSIP: 000899
Website: admabiologics.com

Debt

Debt-to-Equity Ratio: 0.97
Current Ratio: 5.16
Quick Ratio: 1.58

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 12.94

ADMA Technical Analysis vs Fundamental Analysis

Buy
93
ADMA Biologics (ADMA) is a Buy

Is ADMA Biologics a Buy or a Sell?

  • ADMA Biologics stock is rated a Buy
    The current ADMA Biologics [ADMA] share price is $6.60. The Score for ADMA is 93, which is 86% above its historic median score of 50, and infers lower risk than normal.